Liposomal formulation of gp41 derivative with adjuvant MPLA: Vaccine design, immunogenicity in animals and safety in humans


Autoria(s): Malcolm, Karl
Data(s)

2012

Formato

application/pdf

Identificador

http://pure.qub.ac.uk/portal/en/publications/liposomal-formulation-of-gp41-derivative-with-adjuvant-mpla-vaccine-design-immunogenicity-in-animals-and-safety-in-humans(6ca5a46d-58d1-4049-8d32-d690194c713f).html

http://pure.qub.ac.uk/ws/files/1560795/Poster_AIDSVaccine_2012_EN41_120904.pdf

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Malcolm , K 2012 , ' Liposomal formulation of gp41 derivative with adjuvant MPLA: Vaccine design, immunogenicity in animals and safety in humans ' .

Tipo

conferenceObject